Overall (n=1240) ART (n=815) No ART (n=425) P-value
Age (years) 39.1 ± 10.1 40.5 ± 9.7 36.5 ± 10.2 <0.001
Gender       0.4
Male 628 (50.6) 420 (51.5) 208 (48.9)  
Female 612 (49.4) 395 (48.5) 217 (51.1)  
Education (years) 7.5 ± 4.1 7.4 ± 4.1 7.7 ± 4.1 0.2
Skin color       0.9
Caucasian 548 (44.2) 348 (42.7) 182 (42.8)  
Non-Caucasian 692 (55.8) 467 (57,3) 243 (57.2)  
Smoking (pack-years)       0.004
0 422 (34.0) 272 (33.4) 150 (35.3)  
1-19 498 (40.2) 309 (37.9) 189 (44.5)  
=20 320 (25.8) 234 (28.7) 86 (20.2)  
Physical activity (min/week)       0.4
≥150 524 (42.3) 352 (43.2) 172 (40.5)  
<150 716 (57.7) 463 (56.8) 253 (59.5)  
Body mass index (kg/m2)       0.01
<18.5 38 (3.1) 27 (3.3) 11 (2.6)  
18.5-24.9 670 (54.0) 466 (57.2) 204 (48.0)  
25.0-29.9 380 (30.6) 232 (28.5) 148 (34.8)  
≥30.0 152 (12.3) 90 (11.0) 62 (14.6)  
Time since diagnosis of HIV infection (years)       <0.001
<3 485 (39.1) 211 (25.9) 274 (64.5)  
3-5 350 (28.2) 256 (31.4) 94 (22.1)  
≥6 405 (32.7) 347 (42.6) 58 (13.4)  
Viral load (copies/mL)       <0.001
<50 713 (58.4) 321 (39.7) 392 (95.1)  
≥50 508 (41.6) 488 (60.3) 20 (4.9)  
CD4 (cells/mm3)       <0.001
≥350 751 (61.2) 451 (55.6) 300 (72.1)  
200-349 295 (24.0) 215 (26.5) 80 (19.2)  
<200 181 (14.8) 145 (17.9) 36 (8.7)  
Glucose (mg/dL) 86.8 ± 27.6 88.2 ± 29.9 84.3 ± 22.3 0.02
Triglycerides (mg/dL) 151.9 ± 107.5 167.9 ± 121.1 120.6 ± 63.3 <0.001
Total cholesterol (mg/dL) 183.1 ± 43.6 187.9 ± 45.7 173.7 ± 37.5 <0.001
HDL cholesterol (mg/dL) 51.2 ± 13.8 51.9 ± 14.1 49.8 ± 13.1 0.01
LDL cholesterol (mg/dL) 103.0 ± 35.8 104.4 ± 37.4 100.4 ± 32.4 0.07
Dyslipidemia*        
Yes 608 (49.6) 431 (53.3) 177 (42.5) <0.001
No 617 (50.4) 378 (46.7) 239 (57.5)  
Use of lipid-lowering treatment        
Yes 29 (2.3) 26 (3.2) 3 (0.7) 0.006
No 1211 (97.7) 789 (96.8) 422 (99.3)  
* Dyslipidemia: total cholesterol ≥200 md/dL or HDL cholesterol <40 mg/dL
Table 1: Characteristics of HIV-infected patients, stratified by ART use [n(%) or mean ± SD].
Goto home»